Cannabidiol (CBD), a non-psychoactive compound in cannabis, is being touted as beneficial for many health conditions, ranging from anxiety to epilepsy. Although much more research is needed to verify these claims, scientists ...
Apr 17, 2019
0
19
Evidence suggesting an initial half dose of the vaccine being developed by drugs firm AstraZeneca and the University of Oxford is more effective than a full dose is counterintuitive, and even took the researchers by surprise.
Nov 23, 2020
0
9
In a study published in Nature, Christoffer Clemmensen and colleagues demonstrate a new use of the weight loss hormone GLP-1. GLP-1 can be used as a "Trojan Horse" to smuggle a specific molecule into the brain of mice, where ...
May 16, 2024
0
37
(HealthDay)—Early trials of a new form of gene therapy may give hope to patients battling glioblastoma, the most deadly form of brain cancer.
Jun 1, 2015
0
45
In 2007, in an article published in Nature Neuroscience, scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by Joan Guinovart, an authority on glycogen metabolism, reported that in Lafora Disease ...
Feb 27, 2014
0
15
A pair of Vanderbilt University researchers are focusing on proteins that may lead to an inside track on battling COVID-19. Envelope proteins—small membrane proteins—have an important yet unknown role in the development ...
Nov 17, 2020
0
2
A drug-coated nanoparticle reduces plaque buildup in mouse arteries without causing harmful side effects, Stanford School of Medicine researchers have found.
Jan 28, 2020
0
5
Shares of drugmaker Amgen Inc. are rising on news its innovative melanoma drug, which uses a virus as a Trojan horse to infiltrate and destroy tumors, shrank far more tumors than a standard treatment in a late-stage test.
Mar 20, 2013
0
0
From invisible wafts of diesel exhaust to sun-choking plumes of orange smoke, air pollution is known to damage respiratory well-being. Now, research from Rutgers suggests another reason to hold our breath: Polluted air also ...
Nov 15, 2023
0
21
Researchers of MedUni Vienna succeeded in binding allergens to endogenous, endogenic white blood corpuscles to trigger a tolerance reaction in case of a future, possible contact with the respective allergen. The results in ...
Apr 14, 2016
0
33
